Page last updated: 2024-09-02

fingolimod hydrochloride and C gattii Infection

fingolimod hydrochloride has been researched along with C gattii Infection in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	6 (75.00)	24.3611
2020's	2 (25.00)	2.80

Authors

Authors	Studies
Aktas, O; Bielor, C; Hartung, HP; Kremer, D; MacKenzie, C; Müller, AK; Weyers, V; Wienemann, T	1
Bryan, AM; Del Poeta, M; Lazzarini, C; McQuiston, T; Nuesslein-Hildesheim, B; Qiu, Z; Sheridan, B; You, JK	1
Abe, M; Iwakura, Y; Kinjo, Y; Miyazaki, Y; Otani, Y; Sadamoto, S; Shibuya, K; Shimizu, K; Shinozaki, M; Takatsuka, S; Ueno, K; Urai, M; Yanagihara, N	1
Huang, D	1
Achtnichts, L; Conen, A; Fux, CA; Nedeltchev, K; Obreja, O	1
Forrestel, AK; Longworth, S; Micheletti, RG; Modi, BG; Wilck, MB	1
Bernard, JT; Grebenciucova, E; Reder, AT	1
Bornstein, PF; Carpenter, AF; Goodwin, SJ; Larson, AJ; Markus, CK	1

Reviews

1 review(s) available for fingolimod hydrochloride and C gattii Infection

Article	Year
Immunologic mechanisms of fingolimod and the role of immunosenescence in the risk of cryptococcal infection: A case report and review of literature. Multiple sclerosis and related disorders, 2016, Volume: 9 Topics: Cryptococcosis; Female; Fingolimod Hydrochloride; Humans; Immunosenescence; Immunosuppressive Agents; Male; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; T-Lymphocyte Subsets	2016

Other Studies

7 other study(ies) available for fingolimod hydrochloride and C gattii Infection

Article	Year
Cryptococcal meningoencephalitis in an IgG BMC neurology, 2020, Apr-27, Volume: 20, Issue:1 Topics: Cryptococcosis; Female; Fingolimod Hydrochloride; Humans; Immunoglobulin G; Immunosuppressive Agents; Lymphopenia; Meningoencephalitis; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Opportunistic Infections	2020
FTY720 reactivates cryptococcal granulomas in mice through S1P receptor 3 on macrophages. The Journal of clinical investigation, 2020, 09-01, Volume: 130, Issue:9 Topics: Animals; Cell Line; Cryptococcosis; Cryptococcus neoformans; Female; Fingolimod Hydrochloride; Granuloma; Humans; Macrophages, Peritoneal; Male; Mice; Sphingosine-1-Phosphate Receptors	2020
A dendritic cell-based systemic vaccine induces long-lived lung-resident memory Th17 cells and ameliorates pulmonary mycosis. Mucosal immunology, 2019, Volume: 12, Issue:1 Topics: Animals; Cells, Cultured; Cryptococcosis; Cryptococcus gattii; Dendritic Cells; Fingolimod Hydrochloride; Fungal Vaccines; Humans; Immunologic Memory; Immunotherapy, Adoptive; Interleukin-17; Lung; Lymphocyte Activation; Mice; Mice, Inbred C57BL; Mice, Knockout; Th17 Cells	2019
Disseminated cryptococcosis in a patient with multiple sclerosis treated with fingolimod. Neurology, 2015, Sep-15, Volume: 85, Issue:11 Topics: Brain; Cryptococcosis; Fingolimod Hydrochloride; Flucytosine; Humans; Male; Middle Aged; Multiple Sclerosis; Skin; Treatment Outcome	2015
Cryptococcal Meningoencephalitis in a Patient With Multiple Sclerosis Treated With Fingolimod. JAMA neurology, 2015, Volume: 72, Issue:10 Topics: Adult; Brain; Cryptococcosis; Cryptococcus; Fingolimod Hydrochloride; Humans; Male; Meningoencephalitis; Multiple Sclerosis; Treatment Outcome	2015
Primary Cutaneous Cryptococcus in a Patient With Multiple Sclerosis Treated With Fingolimod. JAMA neurology, 2016, Volume: 73, Issue:3 Topics: Cryptococcosis; Cryptococcus neoformans; Female; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Middle Aged; Multiple Sclerosis; Wound Infection	2016
Cutaneous cryptococcosis in a patient taking fingolimod for multiple sclerosis: Here come the opportunistic infections? Multiple sclerosis (Houndmills, Basingstoke, England), 2017, Volume: 23, Issue:2 Topics: Adult; Cryptococcosis; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Male; Middle Aged; Multiple Sclerosis; Opportunistic Infections; Recurrence	2017